125 related articles for article (PubMed ID: 6188108)
1. A mammalian tRNAHis-containing antigen is recognized by the polymyositis-specific antibody anti-Jo-1.
Rosa MD; Hendrick JP; Lerner MR; Steitz JA; Reichlin M
Nucleic Acids Res; 1983 Feb; 11(3):853-70. PubMed ID: 6188108
[TBL] [Abstract][Full Text] [Related]
2. Isolation of a novel antibody, which precipitates ribonucleoprotein complex containing threonine tRNA from a patient with polymyositis.
Okada N; Mukai R; Harada F; Kabashima T; Nakao Y; Yamane K; Ohshima Y; Sakamoto K; Itoh M; Kashiwagi H
Eur J Biochem; 1984 Mar; 139(3):425-9. PubMed ID: 6559690
[TBL] [Abstract][Full Text] [Related]
3. Minor serine tRNA containing anticodon NCA (C4 RNA) from human and mouse cells.
Kato N; Hoshino H; Harada F
Biochem Int; 1983 Nov; 7(5):635-45. PubMed ID: 6435631
[TBL] [Abstract][Full Text] [Related]
4. Two human tRNA(Ala) families are recognized by autoantibodies in polymyositis sera.
Bunn CC; Mathews MB
Mol Biol Med; 1987 Feb; 4(1):21-36. PubMed ID: 3613974
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor binding is limited by the 5'-flanking regions of a Drosophila tRNAHis gene and a tRNAHis pseudogene.
Cooley L; Schaack J; Burke DJ; Thomas B; Söll D
Mol Cell Biol; 1984 Dec; 4(12):2714-22. PubMed ID: 6570190
[TBL] [Abstract][Full Text] [Related]
6. Modulation of transcriptional activity and stable complex formation by 5'-flanking regions of mouse tRNAHis genes.
Morry MJ; Harding JD
Mol Cell Biol; 1986 Jan; 6(1):105-15. PubMed ID: 3641049
[TBL] [Abstract][Full Text] [Related]
7. Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.
Hervier B; Devilliers H; Benveniste O
Ann Rheum Dis; 2013 Jul; 72(7):e18. PubMed ID: 23644669
[No Abstract] [Full Text] [Related]
8. Frequent occurrence of anti-tRNA(His) autoantibodies that recognize a conformational epitope in sera of patients with myositis.
Brouwer R; Vree Egberts W; Jongen PH; van Engelen BG; van Venrooij WJ
Arthritis Rheum; 1998 Aug; 41(8):1428-37. PubMed ID: 9704641
[TBL] [Abstract][Full Text] [Related]
9. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase.
Hirakata M; Suwa A; Takada T; Sato S; Nagai S; Genth E; Song YW; Mimori T; Targoff IN
Arthritis Rheum; 2007 Apr; 56(4):1295-303. PubMed ID: 17393393
[TBL] [Abstract][Full Text] [Related]
10. The leader mRNA of the histidine attenuator region resembles tRNAHis: possible general regulatory implications.
Ames BN; Tsang TH; Buck M; Christman MF
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5240-2. PubMed ID: 6351055
[TBL] [Abstract][Full Text] [Related]
11. Importance of A-loop complementarity with tRNAHis anticodon for continued selection of tRNAHis as the HIV reverse transcription primer.
Ni N; Xu W; Morrow CD
Virol J; 2007 Jan; 4():4. PubMed ID: 17214904
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies specific for U1 RNA and initiator methionine tRNA.
Wilusz J; Keene JD
J Biol Chem; 1986 Apr; 261(12):5467-72. PubMed ID: 2420801
[TBL] [Abstract][Full Text] [Related]
13. Cellular localization of the target structures recognized by the anti-Jo-1 antibody: immunofluorescence studies on cultured human myoblasts.
Shi MH; Tsui FW; Rubin LA
J Rheumatol; 1991 Feb; 18(2):252-8. PubMed ID: 2023220
[TBL] [Abstract][Full Text] [Related]
14. Plant cytosolic tRNAHis possesses an exceptional C54 in the canonical TPsiC loop.
Akama K; Yukawa Y; Sugiura M; Small I
Nucleic Acids Res; 1998 Jun; 26(11):2708-14. PubMed ID: 9592158
[TBL] [Abstract][Full Text] [Related]
15. Six Schizosaccharomyces pombe tRNA genes including a gene for a tRNALys with an intervening sequence which cannot base-pair with the anticodon.
Gamulin V; Mao J; Appel B; Sumner-Smith M; Yamao F; Söll D
Nucleic Acids Res; 1983 Dec; 11(24):8537-46. PubMed ID: 6561518
[TBL] [Abstract][Full Text] [Related]
16. Nucleotide sequence of a spinach chloroplast valine tRNA.
Sprouse HM; Kashdan M; Otis L; Dudock B
Nucleic Acids Res; 1981 Jun; 9(11):2543-7. PubMed ID: 6456449
[TBL] [Abstract][Full Text] [Related]
17. Human BCDIN3D monomethylates cytoplasmic histidine transfer RNA.
Martinez A; Yamashita S; Nagaike T; Sakaguchi Y; Suzuki T; Tomita K
Nucleic Acids Res; 2017 May; 45(9):5423-5436. PubMed ID: 28119416
[TBL] [Abstract][Full Text] [Related]
18. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
[TBL] [Abstract][Full Text] [Related]
19. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
[TBL] [Abstract][Full Text] [Related]
20. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
Dugar M; Cox S; Limaye V; Blumbergs P; Roberts-Thomson PJ
Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
